
Join to View Full Profile
10 E 102nd StNew York, NY 10029
Phone+1 212-241-6756
Dr. Tremblay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2014 - 2017
- Albert Einstein College of MedicineClass of 2014
Certifications & Licensure
- NY State Medical License 2015 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients.James Fan Wu, Erin Jay G Feliciano, Angelica Singh, Douglas Tremblay, Muhammad Bilal Abid
Leukemia. 2025-04-23 - Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a practical guide to diagnosis and management.Douglas Tremblay, Robert P Hasserjian, Raajit K Rampal
Leukemia. 2025-04-19 - 1 citationsHMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosis.Shivani Handa, Christoph Schaniel, Joseph Tripodi, Daiva Ahire, Md Babu Mia
Leukemia. 2025-03-01
Abstracts/Posters
- Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML PatientsDouglas Tremblay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center DatabaseDouglas Tremblay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein ThrombosisDouglas Tremblay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients with AnemiaSeptember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: